chitosan has been researched along with Pneumococcal Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, B; Dai, WJ; Fan, XY; Xu, JH | 1 |
| Chen, B; Dai, W; Fan, X; Li, Z; Wang, Z; Xu, J | 1 |
2 other study(ies) available for chitosan and Pneumococcal Infections
| Article | Year |
|---|---|
Mucosal immunization with PsaA protein, using chitosan as a delivery system, increases protection against acute otitis media and invasive infection by Streptococcus pneumoniae.
Topics: Adhesins, Bacterial; Administration, Intranasal; Animals; Antibodies, Bacterial; Chitosan; Drug Carriers; Female; Immunization; Immunoglobulin A; Immunoglobulin G; Interferon-gamma; Interleukin-17; Interleukin-4; Lipoproteins; Mice; Mice, Inbred BALB C; Nanoparticles; Otitis Media; Pneumococcal Infections; Pneumococcal Vaccines; Streptococcus pneumoniae; Vaccines, Conjugate | 2015 |
Intranasal vaccination with chitosan-DNA nanoparticles expressing pneumococcal surface antigen a protects mice against nasopharyngeal colonization by Streptococcus pneumoniae.
Topics: Adhesins, Bacterial; Administration, Intranasal; Animals; Cell Line; Chitosan; DNA; Female; Humans; Lipoproteins; Mice; Mice, Inbred BALB C; Nanoparticles; Nasopharynx; Pneumococcal Infections; Pneumococcal Vaccines; Streptococcus pneumoniae; Vaccination | 2011 |